CCDI: A New Ligand that Modulates Mammalian Type 1 Ryanodine Receptor (RyR1)

Journal article

Peer reviewed

C. Tian, C. H. Shao, C. Padanilam, E. Ezell, J. Singh, Shelby Kutty and K. R. Bidasee

British Journal of Pharmacology, Vol.171(17), pp.4097-4111

09/2014

Metrics

5 Record Views

Title: CCDI: A New Ligand that Modulates Mammalian Type 1 Ryanodine Receptor (RyR1)
Creators: C. Tian (Author)
C. H. Shao (Author)
C. Padanilam (Author)
E. Ezell (Author)
J. Singh (Author)
Shelby Kutty (Author) - Creighton University
K. R. Bidasee (Author)
Additional links: http://doi.org/10.1111/bph.12764
Publication Details: British Journal of Pharmacology, Vol.171(17), pp.4097-4111
Number of pages: 4097-4111
Identifiers: 991005931404602656
Academic Unit: School of Medicine; Pediatrics
Resource Type: Journal article